Home Uncategorized

Uncategorized

Most popular

Lung Cancer Considered – Episode XXV – Mar 16, 2020 Dr. Marty Edelman Speaks With IASLC President Dr. Tetsuya Mitsudomi

lungcanc

TERAVOLT: Global Registry Investigates Outcomes Among Patients With Thoracic Cancer and COVID-19

TERAVOLT: Increased Risk of Morbidity for Patients with Lung Cancer and COVID-19 Drives Research Collaboration

Insight Into Genomic Correlates of PD-L1 Expression and the Response to Immune Checkpoint Blockade

On the Backs of Specialists: LDCT Screening Has Heightened the Importance of Recent Improvements in Surgical and Radiation Techniques

7th Latin American Conference on Lung Cancer

lungcanc

Stage IIIA NSCLC: A Review of Recent and Ongoing Trials Trial

lungcanc

Pasi A. Janne, MD, PhD

lungcanc

‘Never Too Late’: Tobacco Cessation Programs Benefit Patients With Cancer

lungcanc

The IASLC Fight Against Lung Cancer in Peru and Latin America

lungcanc

Oncology Trials Could Benefit From Increased Data on Tobacco Use

lungcanc

c-MET Antibody–Drug Conjugates: Misconceptions Corrected, Excitement Explained— An Interview with Dr....

lungcanc

Lung Cancer Surgery in the COVID-19 Era: What Has Changed?

lungcanc

IASLC’s Guide to COVID-19 and Lung Cancer

lungcanc

Dr. Harpreet Singh Discusses the Conduct of FDA Clinical Trials During...

lungcanc

12 Page 1 of 2

Meeting News

Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib